Magnetic particle chemiluminescence kit for detecting nitrofural metabolites, and applications thereof

A chemiluminescence reagent, the technology of nitrofurazone, which is applied to the magnetic particle chemiluminescence kit for detecting nitrofurazone metabolites and its application field, can solve the problems of poor reagent stability, reaction time and temperature influence, and achieve low detection time and fast detection , the effect of high sensitivity

Inactive Publication Date: 2013-02-13
BEIJING KWINBON BIOTECH
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The reaction time and temperature have a great influence ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Magnetic particle chemiluminescence kit for detecting nitrofural metabolites, and applications thereof
  • Magnetic particle chemiluminescence kit for detecting nitrofural metabolites, and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The preparation of the concrete component of embodiment one kit

[0035] 1) Synthesis of nitrofurazone metabolite hapten

[0036] The nitrofurazone metabolite is reacted with m-nitrobenzaldehyde to obtain a nitrofurazone metabolite derivative, and then a nitrofurazone metabolite hapten with -COOH is synthesized through a chemical reaction.

[0037] 2) Preparation of nitrofurazone metabolite artificial antigen

[0038] The immunogen was obtained by coupling the nitrofurazone metabolite hapten with bovine serum albumin (BSA) by the mixed anhydride method.

[0039] 3) Preparation of monoclonal antibodies

[0040] Animal immunization: Immunize Balb / c mice with the immunogen at a dose of 100 μg / mouse to produce antiserum.

[0041] Cell fusion and cloning: Splenocytes from immunized Balb / c mice were fused with SP2 / 0 myeloma cells at a ratio of 9:1 to obtain hybridoma cell lines of monoclonal antibodies.

[0042] Cell cryopreservation and recovery: the hybridoma cells were...

Embodiment 2

[0053] The formation of embodiment two kits

[0054] A magnetic particle direct competition chemiluminescent detection kit for detecting nitrofurazone metabolites was constructed so that it contained the following components:

[0055] Fluorescent marker of FITC-labeled nitrofurazone metabolite monoclonal antibody

[0056] Luminescent marker of ABEI-labeled nitrofurazone metabolite hapten

[0057] Separation reagent of paramagnetic nanobeads coated with goat anti-FITC monoclonal antibody

[0058] Furacilin metabolite standard solution (0ng / ml, 0.01ng / ml, 0.03ng / ml, 0.1ng / ml, 0.3ng / ml, 1.0ng / ml), the standard diluent is pH7.4, 0.03%NaN 3 , 0.05mol / L tris buffer. The percentage content is a mass percentage content.

[0059] The concentrations of nitrofurazone metabolite control solution are 0.02ng / ml and 0.5ng / ml respectively, and the diluent of quality control substance is pH7.4, 0.03%NaN 3 , 0.05mol / L tris buffer. The percentage content is a mass percentage content.

[0...

Embodiment 3

[0061] The detection of nitrofurazone metabolites in the actual sample of embodiment three

[0062] 1. Sample pretreatment

[0063] (1) Pretreatment methods for tissues such as muscle and liver

[0064] Use a homogenizer to homogenize the sample and take 1.0±0.05g of homogeneous material. Add 5ml of methanol-water solution, shake with a shaker for 5min, centrifuge at room temperature (20-25°C) for 10min at 3000g, remove all supernatant; (this step can reduce sample matrix interference), add 4ml of deionized water, and vortex Vortex to dissolve, add 0.5ml 1M hydrochloric acid solution and 100μl derivatization reagent, shake fully with a shaker; incubate overnight at 37°C (about 16h); add 5ml 0.1M dipotassium hydrogen phosphate solution, 0.4ml 1M sodium hydroxide respectively Solution and 10ml of ethyl acetate, shake vigorously with a shaker for 30s; centrifuge at room temperature (20-25°C) for 10min above 3000g; take 5ml of ethyl acetate phase into a 10ml dry glass test tube,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a magnetic particle chemiluminescence kit for detecting nitrofural metabolites. The kit comprises a luminous marker, a fluorescein marker, a standard substance, a quality control substance and a separation reagent, wherein the luminous marker is isoluminol luminous marker labeled nitrofural metabolite hapten, the fluorescein marker is fluorescein labeled nitrofural metabolite monoclonal antibody or fluorescein derivative labeled nitrofural metabolite monoclonal antibody, and the separation reagent is sheep anti-FITC monoclonal antibody coated paramagnetic nanometer microbeads. The present invention further relates to a method for detecting nitrofural metabolites in foods of animal origin by using the kit, wherein the method provides characteristics of high sensitivity, high specificity and rapid detection for nitrofural metabolite detection.

Description

technical field [0001] The invention relates to a direct chemiluminescence detection kit and a detection method thereof. Especially the magnetic particle competition direct chemiluminescent detection kit for detecting nitrofurazone metabolite drug residues in samples such as animal tissues, aquatic products, and honey. technical background [0002] Because of their excellent antibacterial and pharmacokinetic properties, nitrofuran drugs have been widely used as growth-promoting additives for poultry, aquatic products and pigs. However, in the course of long-term experimental research, it was found that such drugs and metabolites can cause cancer and gene mutations in experimental animals, so such drugs are prohibited from being used in treatment and feed. Furazone was banned in 1995. [0003] Currently, the common methods used to detect nitrofurazone metabolites are liquid chromatography-mass spectrometry (LC-MS) and enzyme-linked immunosorbent assay (ELISA). [0004] 1. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N21/76G01N33/577
Inventor 万宇平何方洋周德刚韩锐马孝斌崔海峰
Owner BEIJING KWINBON BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products